Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03FIA
|
||||
Former ID |
DCL000628
|
||||
Drug Name |
Rituxan Immunology
|
||||
Drug Type |
Antibody
|
||||
Indication | Pemphigus disease [ICD9: 694.4; ICD10:L10] | Phase 3 | [525110] | ||
Company |
Genentech
|
||||
Structure |
Download2D MOL |
||||
Formula |
C28H34N4O3
|
||||
Canonical SMILES |
CC12C(C(CC(O1)N3C4=C(CCCC4)C5=C6C(=C7C8=C(N2C7=C53)CCCC<br />8)CNC6=O)NC)OC
|
||||
InChI |
1S/C28H34N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h17,20,26,29H,4-13H2,1-3H3,(H,30,33)
|
||||
InChIKey |
VJTABXDSZIOUGU-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD20 | Target Info | [550797] | ||
KEGG Pathway | Hematopoietic cell lineage | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.